Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$83.80 -1.27 (-1.49%)
As of: Oct 21, 2026 · 11:37 AM EDT

Mirum Pharmaceuticals (MIRM) EV to EBITDA (2025)

Updated

Mirum Pharmaceuticals' EV to EBITDA came in at 1762.79 for Q4 2025.

Analysis

Mirum Pharmaceuticals (MIRM) EV to EBITDA (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Mirum Pharmaceuticals 5.33 Bn 3.74 Bn 145.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 965.94
API Access

Mirum Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MIRM&period=max&api_key=YOUR_API_KEY